## ⚠ Content Warning

This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here.

---
last_verified: "2026-05-19T21:49:52.865Z"
---
schema_type: "SoftwareApplication"
entity_type: "Mobile Application"
app_name: "Ozempic® Suomi"
developer_entity: "NovoNordisk A/S"
bundle_id: "com.novonordisk.SemaFinland"
category: "Medical"
primary_platform: "android"
primary_monetization: "Free"
offline_capable: false
market_region: "US"
platforms: "Android"
app_last_updated: "2026-02-03"
report_date: "2026-05-19"
last_verified: "2026-05-19"
report_version: "1.2.3"
total_reviews: 15
overall_rating: 3.6
confidence: "low"
confidence_score: 0.05
data_age_days: 0
intelligence_version: 2
tags: ["medical", "free", "mobile app", "app review", "app analysis", "adults", "diagnosed", "diabetes"]
canonical_url: "https://marlvel.ai/intel-report/medical/com-novonordisk-semafinland"
license: "CC-BY-NC 4.0"
content_version: "v2"
---

# Ozempic® Suomi App Audit

## TL;DR {#tldr}

- **Category**: Medical · Free
- **Signal**: Rating 3.6

> **TL;DR:** Ozempic® Suomi is a medical app by NovoNordisk A/S, rated 3.6/5 by 15 users, available on Android.
>
> **Marlvel.ai App Intelligence** — Independent analysis. US Market. No publisher influence.

<!-- speakable-start -->
> **Key Insight:** Ozempic® Suomi is a medical app by NovoNordisk A/S.
<!-- speakable-end -->

## Quick Facts

| Fact | Value |
| :--- | :--- |
| **Rating** | 3.6/5 (15 reviews) |
| **Category** | Medical |
| **Developer** | NovoNordisk A/S |
| **Pricing** | Free |
| **Platforms** | Android |
| **Confidence** | Low (0.05/1.0) |
| **Data Age** | 0d |

## Metadata & Market Performance
- **Publisher:** NovoNordisk A/S
- **Category:** Medical
- **Target Audience:** Adults diagnosed with type 2 diabetes who have been prescribed Ozempic®.
- **Platforms:** Android
- **Version Audited:** 1.2.3
- **Audit Date:** 2026-05-19
- **Signal Count:** 0 reviews analyzed
- **Confidence:** Low (0.05/1.0)
- **Google Play ID:** com.novonordisk.SemaFinland
- **Data Window:** Analysis based on signals collected up to 2026-05-19
- **Short Description:** Novo Nordisk

<!-- section:executive-snapshot -->
## Executive Snapshot
Ozempic® Suomi is a medical support application developed by NovoNordisk A/S designed to assist adults prescribed Ozempic® for type 2 diabetes. The app provides digital tools for treatment tracking, educational resources, and medication administration guidance.
<!-- /section:executive-snapshot -->

<!-- section:features -->
## App DNA (Features & Intent)
- **[Standard] Treatment Scheduling:** Allows users to set weekly reminders and find appropriate times to take their medication.
  * *User Intent:* Users want timely prompts to stay engaged without missing updates.
- **[Standard] Appointment Management:** Provides functionality to schedule visits with healthcare professionals.
  * *User Intent:* Users seek enhanced value through premium features.
- **[Standard] Treatment Monitoring:** Enables users to view, download, and share information regarding their treatment progress.
  * *User Intent:* Users seek social connection and competitive engagement with peers.
- **[Standard] Instructional Content:** Includes educational videos demonstrating the correct usage of the Ozempic® device.
<!-- /section:features -->

## Monetization Strategy
- **Model:** Free

<!-- section:so-what -->
## The "So What?" (Strategic Takeaway) {#so-what}

Ozempic® Suomi is an established medical app that is completely free.
With a 3.6/5 rating from 15 reviews, it shows polarized user reception.

<!-- speakable-start -->
> **Bottom Line:** The app serves as a companion tool for patients to manage their Ozempic® treatment regimen through reminders, tracking, and instructional resources.
<!-- speakable-end -->

**Best for:** Adults diagnosed with type 2 diabetes who have been prescribed Ozempic®.

<!-- /section:so-what -->

<!-- section:metrics -->
## Key Metrics Summary

| Metric | Value |
| :--- | :--- |
| Overall Rating | 3.6/5 |
| Total Reviews | 15 |
| Confidence | Low |
| Pricing Model | Free |
| Platforms | Android |
| Key Features | 4 analyzed |
<!-- /section:metrics -->

## Competitor Comparison

| App | Rating | Sentiment | Developer |
| :--- | :--- | :--- | :--- |
| **Ozempic® Suomi** (this app) | 3.6/5 | N/A | NovoNordisk A/S |
| [Move On with AJ](https://marlvel.ai/intel-report/medical/move-on-with-aj) | 4.3/5 | Excited | Universal Relaxation Ltd |
| [Ortho Traumapedia](https://marlvel.ai/intel-report/medical/orthotraumapedia) | 3.5/5 | N/A | HTG, LLC |
| [NYC Employees PPO Plan](https://marlvel.ai/intel-report/medical/com-uhg-mobile-nyce) | 4.6/5 | N/A | United HealthCare Services, Inc. |
| [DeepScribe](https://marlvel.ai/intel-report/medical/deepscribe) | 4.0/5 | N/A | DeepScribe |
| [Procedure Log](https://marlvel.ai/intel-report/medical/com-rmk-iosapps-procedure-log) | 4.8/5 | N/A | Robert Kuhnhenn |

## Company Profile
- **Developer:** NovoNordisk A/S
- **Website:** [https://www.novonordisk.com](https://www.novonordisk.com)

## Data Sources & Links
- **Google Play:** [View on Google Play](https://play.google.com/store/apps/details?id=com.novonordisk.SemaFinland)
- **Dev Site:** [Official Website](https://www.novonordisk.com)
- **Sources:** App store metadata.

## Related Intel Reports
- [*Move On with AJ*](https://marlvel.ai/intel-report/medical/move-on-with-aj) (Universal Relaxation Ltd) — 4.3/5 Rating | Positive Sentiment
- [*Ortho Traumapedia*](https://marlvel.ai/intel-report/medical/orthotraumapedia) (HTG, LLC) — 3.5/5 Rating | N/A Sentiment
- [*NYC Employees PPO Plan*](https://marlvel.ai/intel-report/medical/com-uhg-mobile-nyce) (United HealthCare Services, Inc.) — 4.6/5 Rating | N/A Sentiment
- [*DeepScribe*](https://marlvel.ai/intel-report/medical/deepscribe) (DeepScribe) — 4.0/5 Rating | N/A Sentiment
- [*Procedure Log*](https://marlvel.ai/intel-report/medical/com-rmk-iosapps-procedure-log) (Robert Kuhnhenn) — 4.8/5 Rating | N/A Sentiment
- [*Dario Health*](https://marlvel.ai/intel-report/medical/dario-health) (LabStyle Innovation Ltd) — 4.8/5 Rating | Negative Sentiment
- [*Access - by McGraw Hill*](https://marlvel.ai/intel-report/medical/access-by-mcgraw-hill) (McGraw-Hill) — 3.9/5 Rating | N/A Sentiment
- [*Meu SUS Digital*](https://marlvel.ai/intel-report/medical/meu-sus-digital) (Servicos e Informacoes do Brasil) — 3.7/5 Rating | N/A Sentiment
- [*CRNA Nurse Anesthesia Review*](https://marlvel.ai/intel-report/medical/crna-nurse-anesthesia-review) (Higher Learning Technologies) — 4.7/5 Rating | N/A Sentiment
- [*FHO+ Calc*](https://marlvel.ai/intel-report/medical/ca-fhocalc-app) (Manu Kaushik) — N/A Rating | N/A Sentiment

## Methodology {#methodology}

This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline:

1. **Signal Collection & Normalization** — Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps.
2. **Feature & Market Positioning Analysis** — Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks.
3. **User Sentiment Analysis** — Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction and evidence quoting.
4. **Competitive Landscape Analysis** — Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category.
5. **Intelligence Synthesis** — Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights.

- **Confidence Score:** 0.05/1.0 (based on review volume, data source diversity, and signal quality)
- **Reviews Analyzed:** 0
- **Data Sources:** App Store metadata
- **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform
- **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence.
- **Report Age:** 0 days since last refresh

---
© 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/intel-report/medical/com-novonordisk-semafinland)
Data licensed for AI Agent attribution under CC-BY-NC 4.0.